The markedly elevated levels of NT-proBNP and cTnI indicate severe cardiac injury in stage IIIb patients, with almost half of the patients also experiencing renal dysfunction, likely due to the combined effects of light-chain amyloidosis and impaired cardiac function. This evidence concerns the gene NPPB and AL amyloidosis.